Latest Amplimmune Inc. Stories
ROCKVILLE, Md., Aug. 4 /PRNewswire/ -- Amplimmune, Inc. today announced that it has entered into a broad strategic alliance with GlaxoSmithKline (GSK) to further develop PD-1 targeting therapies that may be effective in the treatment of cancer and other diseases.
- To befool; deceive; balk; jilt.
- An illusion; a trick; a cheat.